Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Amitraz Solid Dosage Form

Dissertation (MSc (Applied Science))--University of Pretoria, 2007.

Saved in:
Bibliographic Details
Other Authors: Focke, Walter Wilhelm
Format: Thesis
Published: University of Pretoria 2013
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613667713875968
access_status_str Open Access
author2 Focke, Walter Wilhelm
author_browse Focke, Walter Wilhelm
author_facet Focke, Walter Wilhelm
collection Thesis
dc_rights_str_mv © University of Pretor
description Dissertation (MSc (Applied Science))--University of Pretoria, 2007.
format Thesis
id oai:repository.up.ac.za:2263/27430
institution University of Pretoria (South Africa)
last_indexed 2026-06-10T12:39:47.699Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2013
publishDateRange 2013
publishDateSort 2013
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/27430 Amitraz Solid Dosage Form Focke, Walter Wilhelm lushane@safic.co.za Walbrugh, Lushane Solid dosage forms Amitraz Eutectic Urea 3-dimethylurea 1 UCTD Dissertation (MSc (Applied Science))--University of Pretoria, 2007. This study considered the use of urea eutectics as fast release solid dosage carrier forms for the acaricide N-methylbis (2,4-xylyliminomethyl) methylamine (AmitrazTM). Wettol D2 and Arkopal N090 were chosen as the wetting agent and dispersants respectively. Their optimum levels were determined as the surfactant concentrations that yielded a minimum in the dispersion viscosity of a concentrated (30% m/m) Amitraz suspension. The optimum dosage levels were found to be ca. 2% Arkopal N090 and ca. 1% Wettol D2. Eutectic phase diagrams were obtained using the melting-cooling method. The components were ground together into a fine powder and heated in a glass tube immersed in a silicon oil bath. The liquid was allowed to cool down and solidify at ambient conditions. The time-dependant temperature change of the sample was tracked with a thermocouple. The data was captured in real time on a personal computer and analysed using an Excel spreadsheet programme. The melt-cast method was used to prepare eutectic mixtures. They were characterised using DSC, DTA, XRD and Light Microscopy. The XRD peaks showed the presence of the two separate crystal structures for the eutectic mixture constituents. The urea – CaBr2.2H2O combination was initially considered as carrier for Amitraz. However, this eutectic system was found to be too hygroscopic. Small additions of PEG 6000 improved the tablet strength but decreased the dissolution rate. Urea and acetamide formed a eutectic at ± 46oC with a composition of ca. 40 % m/m urea. Unfortunately acetamide is a suspected carcinogen. Therefore the urea - 1,3-dimethylurea was selected as Amitraz carrier system instead. The eutectic mixture comprised 40% m/m urea and 60% m/m 1,3-dimethylurea, which melt at ± 56oC. The melt-press method was used to prepare Amitraz containing pellets measuring 5 mm thick and 33 mm ö and weighing about 5,0 g. It was possible to suspend Amitraz powder in the eutectic melt mixture provided it remained in powder form. However, when liquefied (by melting), phase separation occurred. Thus the temperature of the eutectic mixture should be kept below the 80oC melting point of Amitraz. The dissolution tests were performed in a 10-liter Pyrex glass beaker with normal tap water (± 25oC). The time taken for complete dissolution was measured with a stopwatch. These results were confirmed with turbidity tests. Starch-based super disintegrants were used in an attempt to enhance the dissolution rate of the pellets. Explotab® improved the dissolution rate of 30% and 40% m/m Amitraz formulations slightly. The best formulation obtained in this study had the following composition (in m/m): 30% Amitraz; 8% CaCO3; 1 % Wettol D2; 2% Arkopal N090; 10% Explotab® and 49% urea – 1,3-dimethylurea eutectic. Such tablets disintegrated within 6,5 minutes when suspended in water. Chemical Engineering MSc unrestricted 2013-09-07T11:30:18Z 2007-08-21 2013-09-07T11:30:18Z 2006-02-12 2007-08-21 2007-08-21 Dissertation Walbrugh, L 2007, Amitraz Solid Dosage Form, MSc Dissertation, University of Pretoria, Pretoria, viewed yymmdd <http://hdl.handle.net/2263/27430> Pretoria http://hdl.handle.net/2263/27430 http://upetd.up.ac.za/thesis/available/etd-08212007-143310/ © University of Pretor application/pdf University of Pretoria
spellingShingle Solid dosage forms
Amitraz
Eutectic
Urea
3-dimethylurea
1
UCTD
Amitraz Solid Dosage Form
title Amitraz Solid Dosage Form
title_full Amitraz Solid Dosage Form
title_fullStr Amitraz Solid Dosage Form
title_full_unstemmed Amitraz Solid Dosage Form
title_short Amitraz Solid Dosage Form
title_sort amitraz solid dosage form
topic Solid dosage forms
Amitraz
Eutectic
Urea
3-dimethylurea
1
UCTD
url http://hdl.handle.net/2263/27430
http://upetd.up.ac.za/thesis/available/etd-08212007-143310/